Searched for
GLAXO SMITHKLINE CONSUMER
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- GSK's Calpol a well-known trademark: High CourtThe Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This desig...
- GSK Consumer Healthcare Q3 profit jumps 25% to Rs 277 croreThe total income of the company rose to Rs 1,274.90 crore as against Rs 1,241.07 crore.
- Buy GlaxoSmithKline Consumer Healthcare, target Rs 7,310: SharekhanBuy GlaxoSmithKline Consumer Healthcare Ltd. at a price target of Rs 7310.0 .
- Buy GlaxoSmithKline Consumer Healthcare, target Rs 6765 : ICICI SecuritiesBuy GlaxoSmithKline Consumer Healthcare Ltd. at a price target of Rs 6765. The stock has been trading at 25 times its FY18 earnings multipl...
- GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
- NSE to drop GlaxoSmithKline Consumer from F&O segmentNSE said it will exclude GlaxoSmithKline Consumer Healthcare from the Futures and Options segment with effect from May 30.
- GlaxoSmithKline Consumer expands Horlicks portfolioHorlicks Kesar Badaam is the fourth variant in the Horlicks portfolio; the other flavours available are Malt, Chocolate and Elaichi.
- GSK gets Sebi nod for GlaxoSmithKline Consumer open offerThe offer is scheduled to open from Jan 17, according to the announcement made by HSBC on behalf of GSK and is expected to close on January...
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...
- Will roll out global brands in phases: Zubair Ahmed, GlaxoSmithKline Consumer HealthcareIndia office of GSK, which has been growing at a rate of 19 pc over the past 5 years, reports directly to the company's headquarters.
- GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.
- GlaxoSmithkline Consumer Q3 net up 25 pc at Rs 128.55 crGlaxoSmithkline Consumer Healthcare Ltd today reported 24.76 per cent jump in net profit at Rs 128.55 crore for the third quarter ended Sep...
- GlaxoSmithKline Consumer Healthcare to focus on breakfast and snack segmentsGlaxoSmithKline Consumer Healthcare (GSKCH) is planning to focus on the breakfast and snack segment as its next growth drivers in India.
- GlaxoSmithkline Healthcare Q1 net up 19 per cent at Rs 132 croreGlaxoSmithkline Consumer Healthcare (GSKCH) today said its net profit rose 19.30 per cent to Rs 131.97 crore for the first quarter ended Ma...
- GSK Consumer Healthcare net up 30 pc at Rs 71.75 crGlaxoSmithKline Consumer Healthcare Ltd reported a 30 per cent jump in net profit for the quarter ended June 30, 2010 at Rs 71.75 crore fro...
- Britannia scouts for overseas buyIt is now the Nusli Wadia-led Britannia’s turn for a global play. The Rs 1,735-crore bakery major is scouting for a significant global acqu...
Load More
